MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ulcerative colitis

Recent news which mentions ulcerative colitis

Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis
Tickers MCRB
Tags Biotech ulcerative colitis Market News
From Benzinga
Pfizer's Ulcerative Colitis Candidate Aces Late-Stage Study
Tickers PFE
Tags Phase 3 Trial Briefs Health Care
From Benzinga
Janssen's Tremfya Shows Clinical Response At 12 Weeks In Ulcerative Colitis
Tickers JNJ
Tags Briefs Biotech ulcerative colitis
From Benzinga
Nearly 66% Of Patients Respond To Eli Lilly's Mirikizumab In Ulcerative Colitis Study
Tickers LLY
Tags ulcerative colitis Health Care Biotech
From Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
Tickers GLMD
Tags Benzinga Movers Briefs
From Benzinga
Seres Posts Interim Microbiome Data Analysis From Failed Ulcerative Colitis Study
Tickers MCRB
Tags ulcerative colitis Biotech General
From Benzinga
Bristol Myers' Zeposia Wins European Approval For Ulcerative Colitis
Tickers BMY
Tags Briefs Biotech Health Care
From Benzinga
Ventyx Jumps Over 20% Today After NASDAQ Debut
Tickers BMY FPX IPO IPOS
Tags News IPO Market News
From Benzinga
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
Tickers BMY
Tags Movers Phase 2 Trial Trading Ideas
From Benzinga
Why Did Kaleido Shares Plunge 10% On Tuesday?
Tickers KLDO
Tags ulcerative colitis Biotech Market News
From Benzinga
Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients
Tickers GLPG GLPGF
Tags ulcerative colitis Health Care Biotech
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
Tickers LLY
Tags General Benzinga News
From Benzinga
AbbVie Submits Upadacitinib Applications In US, Europe For Ulcerative Colitis
Tickers ABBV
Tags Briefs Health Care ABBV
From Benzinga
Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study
Tickers TBPH
Tags News Market News Price Target
From Benzinga
Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study
Tickers JNJ TBPH
Tags Health Care Trading Ideas Phase 2 Trial
From Benzinga
Seres Therapeutics Stock Plunges As Ulcerative Colitis Candidate Disappoints In Mid-Stage Study
Tickers MCRB
Tags Benzinga MCRB Small Cap
From Benzinga
Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients
Tickers GLPG GLPGF
Tags Briefs Health Care ulcerative colitis
From Benzinga
Eli Lilly's Mirikizumab Shows Mucosal Healing In Ulcerative Colitis Maintained For Up To One Year
Tickers LLY
Tags Health Care ulcerative colitis Biotech
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story